These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18627432)

  • 1. Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ.
    Schilling S; Appl T; Hoffmann T; Cynis H; Schulz K; Jagla W; Friedrich D; Wermann M; Buchholz M; Heiser U; von Hörsten S; Demuth HU
    J Neurochem; 2008 Aug; 106(3):1225-36. PubMed ID: 18627432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.
    Cynis H; Scheel E; Saido TC; Schilling S; Demuth HU
    Biochemistry; 2008 Jul; 47(28):7405-13. PubMed ID: 18570439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology.
    Schilling S; Zeitschel U; Hoffmann T; Heiser U; Francke M; Kehlen A; Holzer M; Hutter-Paier B; Prokesch M; Windisch M; Jagla W; Schlenzig D; Lindner C; Rudolph T; Reuter G; Cynis H; Montag D; Demuth HU; Rossner S
    Nat Med; 2008 Oct; 14(10):1106-11. PubMed ID: 18836460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.
    Morawski M; Schilling S; Kreuzberger M; Waniek A; Jäger C; Koch B; Cynis H; Kehlen A; Arendt T; Hartlage-Rübsamen M; Demuth HU; Roßner S
    J Alzheimers Dis; 2014; 39(2):385-400. PubMed ID: 24164736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.
    Schlenzig D; Manhart S; Cinar Y; Kleinschmidt M; Hause G; Willbold D; Funke SA; Schilling S; Demuth HU
    Biochemistry; 2009 Jul; 48(29):7072-8. PubMed ID: 19518051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro).
    Schilling S; Lauber T; Schaupp M; Manhart S; Scheel E; Böhm G; Demuth HU
    Biochemistry; 2006 Oct; 45(41):12393-9. PubMed ID: 17029395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement.
    Buchholz M; Hamann A; Aust S; Brandt W; Böhme L; Hoffmann T; Schilling S; Demuth HU; Heiser U
    J Med Chem; 2009 Nov; 52(22):7069-80. PubMed ID: 19863057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms.
    Hartlage-Rübsamen M; Morawski M; Waniek A; Jäger C; Zeitschel U; Koch B; Cynis H; Schilling S; Schliebs R; Demuth HU; Rossner S
    Acta Neuropathol; 2011 Jun; 121(6):705-19. PubMed ID: 21301857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells.
    Cynis H; Schilling S; Bodnár M; Hoffmann T; Heiser U; Saido TC; Demuth HU
    Biochim Biophys Acta; 2006 Oct; 1764(10):1618-25. PubMed ID: 17005457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl-Peptidase Activity of Meprin β Links N-truncation of Aβ with Glutaminyl Cyclase-Catalyzed pGlu-Aβ Formation.
    Schlenzig D; Cynis H; Hartlage-Rübsamen M; Zeitschel U; Menge K; Fothe A; Ramsbeck D; Spahn C; Wermann M; Roßner S; Buchholz M; Schilling S; Demuth HU
    J Alzheimers Dis; 2018; 66(1):359-375. PubMed ID: 30320570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroglutamate-amyloid-β and glutaminyl cyclase are colocalized with amyloid-β in secretory vesicles and undergo activity-dependent, regulated secretion.
    Cynis H; Funkelstein L; Toneff T; Mosier C; Ziegler M; Koch B; Demuth HU; Hook V
    Neurodegener Dis; 2014; 14(2):85-97. PubMed ID: 24943989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins.
    Chen YL; Huang KF; Kuo WC; Lo YC; Lee YM; Wang AH
    Biochem J; 2012 Mar; 442(2):403-12. PubMed ID: 22060158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Terminal pyroglutamate formation of Aβ38 and Aβ40 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation.
    Schlenzig D; Rönicke R; Cynis H; Ludwig HH; Scheel E; Reymann K; Saido T; Hause G; Schilling S; Demuth HU
    J Neurochem; 2012 Jun; 121(5):774-84. PubMed ID: 22375951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease.
    Morawski M; Hartlage-Rübsamen M; Jäger C; Waniek A; Schilling S; Schwab C; McGeer PL; Arendt T; Demuth HU; Rossner S
    Acta Neuropathol; 2010 Aug; 120(2):195-207. PubMed ID: 20383514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation.
    Hartlage-Rübsamen M; Bluhm A; Piechotta A; Linnert M; Rahfeld JU; Demuth HU; Lues I; Kuhn PH; Lichtenthaler SF; Roßner S; Höfling C
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29673150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of thyrotropin-releasing hormone as hippocampal glutaminyl cyclase substrate in neurons and reactive astrocytes.
    Waniek A; Hartlage-Rübsamen M; Höfling C; Kehlen A; Schilling S; Demuth HU; Roßner S
    Biochim Biophys Acta; 2015 Jan; 1852(1):146-55. PubMed ID: 25446989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease.
    Vijayan DK; Zhang KYJ
    Pharmacol Res; 2019 Sep; 147():104342. PubMed ID: 31288079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerted action of dipeptidyl peptidase IV and glutaminyl cyclase results in formation of pyroglutamate-modified amyloid peptides in vitro.
    Antonyan A; Schlenzig D; Schilling S; Naumann M; Sharoyan S; Mardanyan S; Demuth HU
    Neurochem Int; 2018 Feb; 113():112-119. PubMed ID: 29224965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminyl cyclases display significant catalytic proficiency for glutamyl substrates.
    Seifert F; Schulz K; Koch B; Manhart S; Demuth HU; Schilling S
    Biochemistry; 2009 Dec; 48(50):11831-3. PubMed ID: 19921850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.